BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Shares Outstanding (2021 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Shares Outstanding (Entity) came in at $18.5 million in Q2 2026, up 92.6% on a YoY basis from $9.6 million in Q2 2025, and up 62.39% quarter-over-quarter from $11.4 million in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Shares Outstanding (2021 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Shares Outstanding (Entity) for 6 consecutive years, with $18.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 92.6% year-over-year to $18.5 million; the trailing twelve-month figure through Jun 2026 stood at $18.5 million (up 92.6% YoY), and the FY2025 full-year result was $11.4 million, up 25.29% from the prior year.
  • Shares Outstanding (Entity) grew to $18.5 million in Q2 2026 per BFRG's latest filing, from $11.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $18.5 million in Q2 2026 and bottomed at $4.0 million in Q4 2022.
  • Historically, Shares Outstanding (Entity) has averaged $7.9 million across 5 years, with a median of $7.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) slipped 13.0% in 2022, then soared 92.6% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $4.0 million in 2022, then soared by 51.54% to $6.1 million in 2023, then surged by 49.53% to $9.1 million in 2024, then increased by 25.29% to $11.4 million in 2025, then surged by 62.39% to $18.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $18.5 million, $11.4 million, and $10.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 61.30 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 133.61 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 147.70 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 217.35 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 18.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.81 Mn
Dec 31, 2025 10.34 Mn
Sep 30, 2025 10.38 Mn
Jun 30, 2025 9.71 Mn
Mar 31, 2025 9.69 Mn
Dec 31, 2024 8.25 Mn
Sep 30, 2024 8.12 Mn
Jun 30, 2024 8.12 Mn
Mar 31, 2024 7.39 Mn
Dec 31, 2023 6.05 Mn
Sep 30, 2023 6.09 Mn
Jun 30, 2023 6.06 Mn
Mar 31, 2023 4.84 Mn
Dec 31, 2022 4.01 Mn
Sep 30, 2022 4.75 Mn
Jun 30, 2022 4.63 Mn
Mar 31, 2022 4.62 Mn
Dec 31, 2021 4.12 Mn